“In Trump Time” explains Trump’s vax conundrum

In Peter Navarro’s book “In Trump Time,” he writes about the situation President Trump faced regarding the vaccines and Fauci & Company’s diabolical plan to fill the coffers of Big Pharma.

Trump seemingly “pushed” the vaccines, when in reality, it was the therapeutically HCQ that he pushed before being stymied by Big Media, Big Tech, and Big Pharma.

To wit:

Chapter 7 – THE SCURRILOUS CASE OF HYDROXY HYSTERIA

On March 19, as the US economy was beginning to be shut down in what would be a futile effort to stop the spread of the CCP Virus, President Donald Trump declared that hydroxycholoquine might be a “game changer.” POTUS further promised that the FDA would swiftly provide emergency approval of the potentially lifesaving medicine for treatment of the virus.

The very next day, Dr. Anthony Fauci would stomp all over the president’s message of hope by countering that hydroxychloroquine was not an effective treatment. Ignoring reams of hard scientific evidence in support of the drug’s safety and efficacy, Fauci falsely claimed that any alleged effectiveness of the drug in fighting the virus was “anecdotal.” And he completely ignored an email he had received two days earlier from a prominent scientist who had described hydroxychloroquine as an “effective and safe treatment.”

With Fauci’s throw down, thus began the biggest and bloodiest battle of wills between a US president and a US government employee since President Harry Truman went toe-to-toe with General Douglas MacArthur. Thus also began round two of my fight with a wildly overpaid bureaucrat who would soon emerge as the guiltiest party — along with Jeff Zucker’s CNN — in the Scurrilous Case of Hydroxy Hysteria.

…

EARLY-VERSUS LATE TREATMENT USE

Now here’s a key plot point in the Scurrilous Case of Hydroxy Hysteria, one tied directly to hydroxychloroquine’s alkalinity effect: though numerous scientific studies have found hydroxychloroquine to be highly effective in early treatment of outpatients within the first five to seven days of infection, hydroxychloroquine is likely to be less effective in the late treatment of hospitalized patients.

… Therefore, using hydroxychloroquine in the late treatment stage is like trying to treat the pain of a gunshot would with aspirin.

…

A ROGUE FDA WITH BLOOD ON ITS HANDS

Now you might think that the top doctors and scientists at the US FDA might be smart enough to distinguish between early- and late-treatment use of hydroxychloroquine and shape their policies accordingly. Yet you would be wrong.

Indeed, the FDA committed one of the worst blunders of the entire pandemic by taking what amounted to a rogue and foolish action in defiance of both President Trump and the secretary of the Department of Health and Human Services, Alex Azar. Here’s the story behind this important part of the story.

On March 23, four days after President Trump had promised that the FDA would expedite the use of hydroxychloroquine, Azar and his deputy at HHS, Bob Kadlec, gave several FDA bureaucrats very clear and explicit instructions to make hydroxychloroquine widely available to the American public as an early CCP Virus treatment on an outpatient basis. (As shown by the use of hydroxychloroquine in other countries, early-use outpatient treatment would be an important key to interrupting the exponential spread of the virus and minimize deaths in the United States.)

Nonetheless, five days later, those very same FDA bureaucrats — including FDA commissioner Stephen Hahn and his eventual replacement, Janet Woodcock — completely countermanded the POTUS-Azar-Kadlec order. Instead, on March 28, the FDA issued a rogue directive restricting the use of hydroxychloroquine to the late treatment of hospitalized patients.

With its rogue directive, the FDA effectively ensured that hydroxychloroquine would be diverted from its best possible use as an early treatment for outpatients to its worst possible use as a late-treatment medicine for hospitalized patients. At least in the court of public opinion, that single decision was tantamount if not to murder, then certainly to negligent homicide.

Now I would like to tell you that I uncovered a very good reason in my subsequent investigation as to why Hahn and Woodcock, with the apparent help of Dr. Rick Bright, would make such an egregious decision. Yet in the absence of a smoking gun, all I can do is surmise that the decision was either gross incompetence or an intentional attempt by the Deep Administrative State to sabotage President Trump’s hydroxychloroquine policy. Both are nearly unimaginable.

Either way, there is considerable blood on the hands of the FDA for that decision alone. Yet there would be even more blood on Anthony Fauci’s hands.

FEAR IN HIS EYES, LOATHING IN MINE

On April 4, I had my second major facedown with Saint Fauci in the Situation Room. Recall that in my first go-round with him on January 28, Fauci had strenuously opposed President Trump’s travel ban on China. If we had not prevailed in that fight, hundreds of thousands and perhaps millions of Americans would have needlessly died due to Fauci’s bad advice.

This time, the facedown with Fauci was over hydroxychloroquine. In preparation, I had Doc Hatfill and y team prepare a large dossier with the hundreds of pages of scientific studies I had reviewed on the safety and efficacy of hydroxychloroquine. I knew that Fauci would play the “there’s only anecdotal evidence” card and wanted to be ready to prove that that assertion was fake.

The meeting started off civilly enough. Vice President Mike Pence was at the head of the table, chairing the meeting, along with his chief of staff Marc Short; Jared Kushner had come to make a cameo appearance; and the big guests of honor were Fauci along with Surgeon General Jerome Adams and the FDA’s Hahn.

To my pleasant surprise, at the outset of the meeting, the surgeon general offered strong words of approval in support of hydroxychloroquine along the lines of “The medicine certainly can’t hurt you, and there seems to be some evidence that it may help.”

I greatly appreciate those words because I knew he was taking a risk. His peers — Fauci in particular — might well try to come down hard on him.

Adams was followed by Hahn, and to my surprise, even Hahn had some encouraging words for hydroxychloroquine — perhaps because of all the heat the FDA had been taking for its moronic March 28 directive.

That support from Adams and Hahn notwithstanding, when it was Fauci’s turn, right on cue, he immediately played his “there’s only anecdotal evidence” card. Just as immediately, I stood up from my backbench chair just behind Vice President Pence and walked straight toward Fauci.

As I approached him, I saw fear in his eyes. I’m sure it crossed his mind that I might physically assault him. Instead, I dumped my large dossier of studies onto the table in front of him and said to Fauci as much as to everyone else in the room — especially VPOTUS — “Tony, these are not anecdotes. That’s ore than fifty scientific studies in support of hydroxy. Fifty! So stop spouting your crap about there only being anecdotal evidence because not only is it counterfactual. You are going to kill people just like you did during the AIDS crisis when you refused to approve medicines that everybody but you knew worked.”

Now, keep in mind that discussions conducted in the Situation Room are generally considered confidential. Yet — and there was only a very small handful of very senior officials attending this meeting — my confrontation with Fauci was immediately leaked to Jonathan Swan at the DC gossip website Axios.

Swann, as I liked to call him whenever he called to confirm a fact or try to coax a leak from me, gave a detailed account of what he described as an “epic Situation Room showdown” featuring a “heated exchange” between Fauci and me.

His reporting was not wrong. But that kind of leak was just not right — and I told him so.

At least my confrontation with Fauci would shut him up for a couple of days. Then a tragic hat trick of Hydroxy Hysteria would hit Doc Hatfill, POTUS, and me harder than an Alex Ovechkin body check.

THE FRENCH MISCONNECTION

This tragedy of scientific errors began on April 14, 2020, with a French study posted on the online bulletin board medRxiv. Its Yale sponsorship notwithstanding, the website is an embarrassment that does far more harm than good. It does so by providing a thin patina of respectability to any kind of so-called research that hacks around the world might want to post without adequate peer review.

The French hacks in question took a small sample of amore 181 patients stuck in a French hospitalnin the late-treatment stages father infection and divided them into one group that received hydroxochloroquine and a “control group” that did not. Not surprisingly, the researchers found no difference in mortality rates between the two groups.

…

To fully understand the “blood on their hands” implications of the FDA’s announcement, it may be time to stop and do a little Hydroxy Hysteria Grim Reaper math. Consider then, those 63 million…

…

OK, to read the rest, get the book!

By Radiopatriot

A former talk radio host turned political activist, diving deep into the intricacies of political warfare and sharing insights on the shadow government and 5th Generation Psy-Ops. RadioPatriot's been diving into political intrigue, from FBI hearings to questioning staged events. Twitter.com/RadioPatriot * Telegram/Radiopatriot * Telegram/Andrea Shea King Gettr/radiopatriot * TRUTHsocial/Radiopatriot

Leave a comment